Within this 16-record search scope, one company accounts for the entire ranked field — 100% of the records the assignee ranking returns. That does not mean no other company has ever filed in this space; it means that within this specific keyword and IPC scope, no second assignee appears. A broader search across adjacent classification codes would likely surface additional filers, since a field this concentrated is often a sign the search boundary is narrower than the real technology space.

Filing activity peaked at 14 records in 2021 and then dropped to zero by the 2022 midpoint, staying flat through the most recent partial year. Because publication typically lags actual filing by around 18 months, the most recent one to two years understate real activity, so it is too early to call this a genuine decline. The size of the post-2021 drop is larger than lag alone would explain, which makes this a trend worth revisiting once more recent filings publish.

All 16 records in scope are classified under A61F, which covers implants and prostheses including ostomy skin barriers and related devices. Smaller numbers of records also touch sterilising and disinfecting methods, polymer compositions, mechanical testing apparatus and healthcare informatics — each appearing in only one record. That imbalance suggests the field's patent activity is concentrated on the core barrier and adhesive technology rather than on adjacent materials science, testing methodology or digital health angles.

This filing describes a skin adhesive or ostomy skin barrier that incorporates a pH indicator encapsulated in mesoporous particles, changing colour in response to pH shifts at the skin interface. It ties peristomal skin health monitoring directly into the adhesive material itself, rather than requiring a separate wearable sensor or electronic device. For anyone developing a competing adhesive or barrier product with any kind of integrated skin-condition indicator, this claim scope is worth checking closely before finalising a formulation.

The clearest gaps sit in the branches that appear in only one of the 16 records: sterilisation-compatibility testing for adhesives, polymer composition tuning specifically for wear-time extension, mechanical leakage-test rig design, and informatics or analytics layered onto ostomy care data. Each of these is technically adjacent to the dominant A61F barrier claims but has barely been developed within this search scope. A first claim in any of these areas would need to establish novelty against the single dominant assignee's broader portfolio, but the thin coverage here suggests that portfolio has not yet staked out these specific angles.